We're increasing our Eli Lilly price target after another beat-and-raise quarter
The strength of its GLP-1 business suggests the stock still has more room to run.
We're increasing our Eli Lilly price target after another beat-and-raise quarter
Friday, 11 September 2026
News, business, world affairs and market coverage
We're increasing our Eli Lilly price target after another beat-and-raise quarter
The strength of its GLP-1 business suggests the stock still has more room to run.